HLA-DRB5 (Major Histocompatibility Complex, Class II, DR Beta 5)

News alerts, weekly reports and conference planners

Entrez ID:

EGFR mutation + HLA-DRB5 rs1071748	Lung Cancer	EGFR mutation + HLA-DRB5 rs1071748	Lung Cancer	EGFR inhibitor Resistant: C3 – Early Trials EGFR inhibitor Resistant : C3	EGFR inhibitor Resistant: C3 – Early Trials EGFR inhibitor Resistant : C3
EGFR mutation + HLA-DRB5 rs184278615	Lung Cancer	EGFR mutation + HLA-DRB5 rs184278615	Lung Cancer	EGFR inhibitor Resistant: C3 – Early Trials EGFR inhibitor Resistant : C3	EGFR inhibitor Resistant: C3 – Early Trials EGFR inhibitor Resistant : C3
EGFR mutation + HLA-DRB5 rs20146916	Lung Cancer	EGFR mutation + HLA-DRB5 rs20146916	Lung Cancer	EGFR inhibitor Resistant: C3 – Early Trials EGFR inhibitor Resistant : C3	EGFR inhibitor Resistant: C3 – Early Trials EGFR inhibitor Resistant : C3

Associations(3)